Product Fact Sheet

VitaEPA Double Strength

VitaHealth VitaEPA Double Strength provides 360mg of EPA and 240mg of DHA in one convenient softgel. These omega-3 fatty acids are important for normal bodily functions and maintenance of general well-being.

It provides readily available EPA and DHA that body cannot synthesise and can only be obtained through diet.

Omega-3 fatty acids are also vital components to substances of prostaglandins and leukotrienes which play an important role in immune function.

Each softgel contains:

Omega-3 Fish Oil
providing total omega-3 fatty acids 600mg
eicosapentaenoic acid (EPA) 360mg
docosahexaenoic acid (DHA) 240mg

1200mg

Grape Seed Extract (Vitis vinifera) 100mg

100mg

providing 95% proanthocyanidins

Directions:

Adults – Take 1 softgel, once daily, after a meal or as
recommended by a doctor or pharmacist.

Why Choose VitaHealth VitaEPA Double Strength?

Molecularly distilled for purity and stability – Removal of contaminants such as heavy metal, dioxins and PCBs
Once-a-day dose
Recommended for individuals with borderline and high triglycerides levels (>150 mg/dL or 1.7 mmol/L)
Halal-certified

Benefits

Omega-3 Marine Lipid Concentrate Natural Fish Oil

Decreases risk for cardiovascular diseases
Lowers (slightly) blood pressure
Lowers triglyceride and remnant lipoprotein very low-density lipoprotein (VLDL) levels
Inhibits development of plaque in arteries
Prevents clots and decreases risk for thrombosis, which can lead to heart attack and stroke
Delays the onset of Alzheimer’s disease or dementia by reducing brain inflammatory state
Reduces the risk of depressive symptoms

Target Customers

Individuals with high triglycerides
Individuals with high blood pressure
Individuals with dry eye symptoms
Individuals with family history of cardiovascular disease

References :

Harris WS (2004) Fish oil supplementation: evidence for health benefits. Cleve Clin J Med. 71:208–10.212
Kinsella JE, Lokesh B, Stone RA (1990) Dietary n-3 polyunsaturated fatty acids and amelioration of cardiovascular disease: possible mechanisms. Am J Clin Nutr ;52:1–28
Kris-Etherton PM, Harris WS, Appel LJ (2002) American Heart Association Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation; 106:2747–57. doi:
10.1161/01.CIR.0000038493.65177.94
Saito Y, Yokoyama M, Origasa H, Matsuzaki M (2008) Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis;200:135–40